Glyco-nanoparticles: New drug delivery systems in cancer therapy

Area of Science:

• Nanomedicine and Oncology
• Materials Science
• Biotechnology

Background:

• Cancer remains a leading cause of global mortality, with current treatments often exhibiting toxicity and limited specificity.
• Nanotechnology has emerged as a powerful tool for developing advanced drug delivery systems.
• Nanosized drug delivery systems offer enhanced tumor selectivity and controlled release of anticancer agents.

Purpose of the Study:

• To review recent advancements in multifunctional glycol-nanoparticles (GNPs) for cancer drug delivery.
• To highlight the potential of carbohydrate-functionalized nanomaterials in targeted cancer therapy.

Main Methods:

• Review of current research on various nanoparticle types, including silicon-based nanomaterials, polymers, liposomes, and metal nanoparticles.
• Focus on carbohydrate-functionalized nanomaterials for their multi-valent binding and biocompatibility.
• Exploration of intracellular delivery platforms utilizing carbohydrate-modified nanoparticles (e.g., metal NPs, quantum dots, magnetic nanomaterials).

Main Results:

• Carbohydrate-functionalized nanomaterials demonstrate significant potential as drug carriers due to their biocompatibility and binding capabilities.
• Glycol-nanoparticles (GNPs) are identified as promising candidates for controlled and targeted release of therapeutic agents.
• These GNPs facilitate the development of sophisticated intracellular delivery platforms for enhanced anticancer efficacy.

Conclusions:

• Multifunctional glycol-nanoparticles represent a significant advancement in targeted cancer drug delivery.
• The unique properties of carbohydrate-functionalized nanomaterials offer a pathway to overcome limitations of conventional cancer therapies.
• Further research into GNPs is crucial for developing more effective and selective cancer treatment strategies.